Cognitive behavioral rehabilitation for bipolar disorder patients: A randomized controlled trial

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
BIPOLAR DISORDERS, v.21, n.7, p.621-633, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives Bipolar disorder is frequently associated with cognitive impairment even during euthymia. Previous studies have reported significant impairments in functional and quality of life outcomes and a possible relationship between these variables and cognitive performance. Cognitive rehabilitation interventions have been proposed to address these outcomes but positive results are still scarce. The objective of the present study is to evaluate the efficacy of a new intervention developed to address both cognitive and functional impairment. Methods Thirty-nine individuals were included in this randomized controlled trial. All participants were evaluated by the Cambridge Neuropsychological Test Automated Battery (CANTAB) and completed functional and quality of life (QOL) scales. Patients were randomized to either treatment as usual (TAU) or Cognitive Behavior Rehabilitation (CBR), an add-on treatment delivered in 12 weekly group sessions. All individuals were revaluated after 12 weeks. Results A total of 39 bipolar type I or II patients were included in the analysis, 19 in the TAU group and 20 in the CBR condition. At the entrance of the study, both groups were statistically similar regarding clinical, socio-demographics and cognitive variables. After the end of the intervention, CBR individuals had significantly improved reaction time, visual memory and emotion recognition. In contrast, individuals in the CBR did not present a statistically change in functional and QOL scores after the 12-week intervention. Conclusions CBR intervention showed promising results in improving some of the commonly impaired cognitive domains in BD. A longer follow-up period may be necessary to detect changes in functional and QOL domains.
Palavras-chave
bipolar disorder, cognitive rehabilitation, cognitive therapy, functional impairment, psychotherapy
Referências
  1. Andreou C, 2013, CURR OPIN PSYCHIATR, V26, P54, DOI 10.1097/YCO.0b013e32835a2acf
  2. Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131
  3. Bonnin CM, 2016, BRIT J PSYCHIAT, V208, P87, DOI 10.1192/bjp.bp.114.162123
  4. Bora E, 2017, PSYCHOL MED, V47, P2753, DOI 10.1017/S0033291717001490
  5. Burdick KE, 2014, PSYCHOL MED, V44, P3083, DOI 10.1017/S0033291714000439
  6. Cacilhas AA, 2009, VALUE HEALTH, V12, P624, DOI 10.1111/j.1524-4733.2008.00481.x
  7. Cipriani G, 2017, J NERV MENT DIS, V205, P743, DOI 10.1097/NMD.0000000000000720
  8. Combs Dennis R, 2007, Cogn Neuropsychiatry, V12, P128, DOI 10.1080/13546800600787854
  9. CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G
  10. Deckersbach T, 2018, J AFFECT DISORDERS, V229, P342, DOI 10.1016/j.jad.2017.12.041
  11. Deckersbach T, 2014, AM J PSYCHIAT, V171, P178, DOI 10.1176/appi.ajp.2013.13020225
  12. Deckersbach T, 2010, CNS NEUROSCI THER, V16, P298, DOI 10.1111/j.1755-5949.2009.00110.x
  13. Demant KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127955
  14. Demant KM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-378
  15. Depp CA, 2012, BIPOLAR DISORD, V14, P217, DOI 10.1111/j.1399-5618.2012.01011.x
  16. Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750
  17. Fenger M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1619-3
  18. First M.B., 2004, COMPREHENSIVE HDB PS, P134, DOI [DOI 10.1002/CPP, 10.1002/9780471726753]
  19. Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012
  20. Gomes BC, 2011, PSYCHOTHER PSYCHOSOM, V80, P144, DOI 10.1159/000320738
  21. Gomes BC, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1896-5
  22. Grace J., 2001, FRONTAL SYSTEMS BEHA
  23. Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7
  24. Hsiao YL, 2009, BIPOLAR DISORD, V11, P547, DOI 10.1111/j.1399-5618.2009.00723.x
  25. Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P156, DOI 10.1097/01.jom.0000052967.43131.51
  26. Lahera G, 2013, J AFFECT DISORDERS, V146, P132, DOI 10.1016/j.jad.2012.06.032
  27. Lam DH, 2003, ARCH GEN PSYCHIAT, V60, P145, DOI 10.1001/archpsyc.60.2.145
  28. Leon AC, 1999, PSYCHOL MED, V29, P869, DOI 10.1017/S0033291799008570
  29. Michalak Erin E, 2005, Health Qual Life Outcomes, V3, P72, DOI 10.1186/1477-7525-3-72
  30. Miklowitz DJ, 2008, AM J PSYCHIAT, V165, P1408, DOI 10.1176/appi.ajp.2008.08040488
  31. MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
  32. Nenadic I, 2015, PSYCHIAT RES, V230, P65, DOI 10.1016/j.psychres.2015.08.012
  33. Nierenberg AA, 2009, CLIN TRIALS, V6, P637, DOI 10.1177/1740774509347399
  34. Perna G, 2017, PSYCHIAT INVEST, V14, P8, DOI 10.4306/pi.2017.14.1.8
  35. Roberts DL, 2009, PSYCHIAT RES, V166, P141, DOI 10.1016/j.psychres.2008.02.007
  36. Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016
  37. Rosa Adriane R, 2007, Clin Pract Epidemiol Ment Health, V3, P5, DOI 10.1186/1745-0179-3-5
  38. Rosa AR, 2013, J AFFECT DISORDERS, V150, P29, DOI 10.1016/j.jad.2013.02.022
  39. Roux P, 2017, BIPOLAR DISORD, V19, P146, DOI 10.1111/bdi.12485
  40. Ryan KA, 2017, BIPOLAR DISORD, V19, P689, DOI 10.1111/bdi.12532
  41. SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695
  42. Samame C, 2012, ACTA PSYCHIAT SCAND, V125, P266, DOI 10.1111/j.1600-0447.2011.01808.x
  43. Scott J, 2006, BRIT J PSYCHIAT, V188, P313, DOI 10.1192/bjp.188.4.313
  44. Seidel EM, 2012, J PSYCHIATR RES, V46, P382, DOI 10.1016/j.jpsychires.2011.11.006
  45. Strawbridge R, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1472-4
  46. Thonse U, 2018, PSYCHIAT RES, V264, P354, DOI 10.1016/j.psychres.2018.03.027
  47. Torrent C, 2013, AM J PSYCHIAT, V170, P852, DOI 10.1176/appi.ajp.2012.12070971
  48. Tse S, 2014, BIPOLAR DISORD, V16, P217, DOI 10.1111/bdi.12148
  49. Veeh J, 2017, INT J BIPOLAR DISORD, V5, DOI 10.1186/s40345-017-0079-3
  50. Vlad M, 2018, EUR PSYCHIAT, V52, P116, DOI 10.1016/j.eurpsy.2018.05.002
  51. Wigman JTW, 2014, PSYCHOL MED, V44, P325, DOI 10.1017/S0033291713000871
  52. YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429